Stem cells have attracted a great deal of deserved attention due to their lineage-independent characteristics. In other words, they have the potential to be differentiated into a countless number of cell types. Adult stem cells, otherwise known as inducible pluripotent stem cells (iPSCs), are particularly favorable as research tools because they are derived from a patient’s somatic cells such as blood, skin or muscle.

This month, the Supplier Spotlight™ is on SciQuus Oncology, an oncology-focused clinical research organization committed to the advancement of your clinical research program.